Stock 600867 TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tonghua Dongbao Pharmaceutical Co., Ltd.

Equities

600867

CNE000000H87

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
10.59 CNY +4.03% Intraday chart for Tonghua Dongbao Pharmaceutical Co., Ltd. +5.58% -2.22%
Apr. 26 Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 29 Dongbao Pharma's 2023 Profit Drops 26% MT

Business Summary

TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides biological products, traditional Chinese medicines and chemical supplements, applied in the treatment of diabetes and cardiovascular and cerebrovascular diseases, among others. The Company's main products portfolio consists of recombinant human insulin bulk drugs and injections, zhennaoning capsules, among others. The Company also provides medical instruments, plastic-steel windows and profiles, and operates property business. The Company distributes its products within domestic markets and to overseas markets.

Number of employees: 3,196

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical
94.7 %
2,731 98.3 % 2,914 94.7 % +6.69%
Other Business
4.7 %
36 1.3 % 146 4.7 % +299.83%
Real Estate
0.5 %
9 0.3 % 15 0.5 % +67.50%
Building Materials
0.0 %
2 0.1 % 0 0.0 % -74.64%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.1 %
2,696 98.3 % 3,018 98.1 % +11.96%
Abroad
1.9 %
46 1.7 % 57 1.9 % +23.90%

Managers

Managers TitleAgeSince
Chun Sheng Leng CEO
 Chief Executive Officer 50 -
Feng Qin Li BRD
 Director/Board Member 64 -
Liping Gu IRC
 Investor Relations Contact - -
Fan Su SEC
 Corporate Secretary 45 20-06-16

Members of the board

Members of the board TitleAgeSince
Jun Ye Wang CHM
 Chairman 59 20-09-27
Feng Qin Li BRD
 Director/Board Member 64 -
Ya Ren An BRD
 Director/Board Member 69 -
Chun Sheng Leng CEO
 Chief Executive Officer 50 -
Ming Li He BRD
 Director/Board Member 62 -
Dian Duo Wang BRD
 Director/Board Member 66 -
Fu Bo Cao BRD
 Director/Board Member 55 -
Wei Shi BRD
 Director/Board Member 65 -
Yan Ming Wang BRD
 Director/Board Member 56 -
Qing Xia He BRD
 Director/Board Member 45 94-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,992,896,932 1,179,291,871 ( 59.17 %) 1,162,879 ( 0.0584 %) 59.17 %

Shareholders

NameEquities%Valuation
Dongbao Industrial Group Co. Ltd.
29.54 %
591,699,387 29.54 % 839 M ¥
Tianjin Zhenyi Enterprise Management Consulting LP
9.139 %
183,058,967 9.139 % 260 M ¥
Abu Dhabi Investment Authority (Investment Management)
1.589 %
31,836,912 1.589 % 45 M ¥
Citic Securities Co., Ltd. (Invt Port)
1.458 %
29,208,384 1.458 % 41 M ¥
China Merchants Fund Management Co., Ltd.
1.241 %
24,855,851 1.241 % 35 M ¥
Yinhua Fund Management Co., Ltd.
0.6264 %
12,547,411 0.6264 % 18 M ¥
Yi Kui Li
0.5656 %
11,328,579 0.5656 % 16 M ¥
Jian Xin Wu
0.5484 %
10,983,950 0.5484 % 16 M ¥
GF Fund Management Co., Ltd.
0.5406 %
10,828,299 0.5406 % 15 M ¥
China Southern Asset Management Co., Ltd.
0.4908 %
9,831,433 0.4908 % 14 M ¥

Holdings

NameEquities%Valuation
XIAMEN AMOYTOP BIOTECH CO., LTD.
16.03%
 65,200,114 16.03% 558,862,125 $

Company contact information

Tonghua Dongbao Pharmaceutical Co., Ltd.

Dongbao New Village

134123, Tonghua

+

http://www.thdb.com
address Tonghua Dongbao Pharmaceutical Co., Ltd.(600867)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Tonghua Dongbao Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
10.59 CNY
Average target price
15.27 CNY
Spread / Average Target
+44.22%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. Stock Tonghua Dongbao Pharmaceutical Co., Ltd.
-2.22% 2.9B
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.09% 15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 600867 Stock
  4. Company Tonghua Dongbao Pharmaceutical Co., Ltd.